Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2007-9-5
pubmed:abstractText
The MHC-encoded butyrophilin, BTN2A1, is a cell surface glycoprotein related to the extended family of B7 costimulatory molecules. BTN2A1 mRNA was expressed in most human tissues, but protein expression was significantly lower in leukocytes. An Ig-fusion protein of BTN2A1 bound to immature monocyte-derived dendritic cells. Binding diminished upon MoDC maturation and no binding was detected to Langerhans cells. Induction of the counterreceptor was IL-4 dependent and occurred early during dendritic cell differentiation. The interaction required the presence of Ca2+ and was mediated by high-mannose oligosaccharides. These properties matched DC-SIGN, a DC-specific HIV-1 entry receptor. This was confirmed by binding of soluble BTN2A1 to DC-SIGN-transfectants and its inhibition by a specific Ab. DC-SIGN bound to native BTN2A1 expressed on a range of tissues. However, BTN2A1 was not recognized on some normal cells such as HUVECs despite a similar expression level. The BTN2A1 of tumor cells such as HEK293T have more high-mannose moieties in comparison to HUVECs, and those high-mannose moieties are instrumental for binding to DC-SIGN. The data are consistent with tumor- or tissue-specific glycosylation of BTN2A1 governing recognition by DC-SIGN on immature monocyte-derived dendritic cells.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
179
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3804-11
pubmed:meshHeading
pubmed-meshheading:17785817-Animals, pubmed-meshheading:17785817-Antigens, CD80, pubmed-meshheading:17785817-Cell Adhesion Molecules, pubmed-meshheading:17785817-Cell Differentiation, pubmed-meshheading:17785817-Cell Line, Tumor, pubmed-meshheading:17785817-Cells, Cultured, pubmed-meshheading:17785817-Dendritic Cells, pubmed-meshheading:17785817-Gene Expression Regulation, pubmed-meshheading:17785817-Glycosylation, pubmed-meshheading:17785817-HeLa Cells, pubmed-meshheading:17785817-Humans, pubmed-meshheading:17785817-Jurkat Cells, pubmed-meshheading:17785817-Langerhans Cells, pubmed-meshheading:17785817-Lectins, C-Type, pubmed-meshheading:17785817-Ligands, pubmed-meshheading:17785817-Membrane Glycoproteins, pubmed-meshheading:17785817-Mice, pubmed-meshheading:17785817-Receptors, Cell Surface, pubmed-meshheading:17785817-Recombinant Fusion Proteins, pubmed-meshheading:17785817-Structural Homology, Protein, pubmed-meshheading:17785817-Transfection
pubmed:year
2007
pubmed:articleTitle
The B7 homolog butyrophilin BTN2A1 is a novel ligand for DC-SIGN.
pubmed:affiliation
Department of Pathology, Division of Immunology, University of Cambridge, Cambridge, United Kingdom. gfjm2@cam.ac.uk
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't